Stockreport

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

LivaNova PLC - Ordinary Shares  (LIVN) 
Last livanova plc - ordinary shares earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: livanova.com
PDF – First and only hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language– Next-generation, M [Read more]